Company Info
| Phone: | (585) 271-2700 |
| Year Established: | 1997 |
| Ticker: | VCNX |
| Exchange: | Nasdaq |
Contacts
| Primary: | John E. Leonard, Ph.D. Senior VP, Development & Officer |
| Other: | Maurice Zauderer, Ph.D. Founder, President & CEO Jill Sanchez, CPA CFO Ernest Smith, Ph.D. Senior VP, R&D & CSO Elizabeth E. Evans, Ph.D. COO & Sr. VP, Discovery & Translational Medicine John E. Leonard, Ph.D. Senior VP, Development |
Company Description
Vaccinex is pioneering a differentiated approach to treating neurodegenerative disease through the inhibition of semaphorin 4D (SEMA4D), a key driver of neuroinflammation.
